Rayner Surgical Group

Developer and manufacturer of intra-ocular lenses

rayner.com
Date Invested
January 2017
Status
Current

At a glance

>80
countries exported to
>650,000
eyes with improved vision per year
3
new products launched since investment

Rayner is a leading developer and manufacturer of ophthalmic implants and pharmaceuticals. Led by CEO Tim Clover, it specialises in providing intra-ocular lenses and related products used in cataract and refractive surgery that improve the eyesight of patients worldwide.

Rayner is a global business. Its products are available in over 80 countries through its own subsidiaries in the United Kingdom, USA, Italy and Spain and through a wide network of distributors.

Our partnership

Phoenix is working with the Rayner team to further accelerate the development of a number of new products, and to strengthen its international reach. Together we are also assessing a number of strategic acquisition opportunities.

"Our partnership with Phoenix is helping to accelerate our growth plans by providing us with the support and resources to develop and launch new products, contributing to improvements in visual outcomes for surgeons and patients worldwide."

Tim Clover, CEO of Rayner Surgical Group